Search
for
Sort by
Research 181–210 of 306
- Androgen Secreting Steroid Cell Tumor of the Ovary Represented with Postmenopasal Bleeding and Extensive Hirsutism
- Gonads
- Hormonal acne: leading to a paradigm shift in the management of acne
- Clinical Approaches to PCOS: A Survey of the NASPAG Membership
- Screening for Abnormal Glucose Metabolism in Adolescents with Polycystic Ovary Syndrome (PCOS)
- Androgen Treatment in Women
- Syndromes of Severe Insulin Resistance (SSIRs)
- Dermatological Issues in a Child with Diabetes Mellitus
- Molecular genetics of androgen insensitivity
- Hormonal treatment of acne vulgaris: an update
- Interventions for female pattern hair loss
- Gender-Affirming Hormone Therapy for Transgender Men
- Alopecia and Hirsuties
- “Occult” ovarian Leydig cell tumor: when laboratory tells more than imaging
- Virilización y enfermedad metabólica en mujer postmenopáusica relacionado a hiperplasia e hipertecosis ovárica
- Síndrome de ovario poliquístico: la distancia anogenital como marcador del entorno androgénico prenatal y revisión y comparación de los criterios diagnósticos
- Workup and Management of Polycystic Ovary Syndrome
- Ovarian vein sampling, and serum and urine testosterone monitoring in ovarian Leydig cell tumors: A report of two cases
- Post Menopausal Hyperandrogenism: A Case of a Steroid Cell Tumor of the Ovary
- MON-336 Ovaries Reveal Their Inner Testes
- Virilization from partner's use of topical androgen in a reproductive-aged woman
- Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
- Aldosterone- and cortisol-cosecreting adrenal adenoma, ovarian hyperthecosis and breast cancer
- SUN-115 Leydig Cell Tumor: A Rare Cause of Hyperandrogenism
- A RARE ENCOUNTER
- Secondary Amenorrhea and Clinical Hyperandrogenism in a 34-Year-Old Female: Polycystic Ovary Syndrome or Not?
- VIRILISING OVARIAN TUMOUR
- THU646 Postmenopausal Hyperandrogenism Secondary To Ovarian Leydig Cell Tumor
- DIAGNOSTIC AND THERAPEUTIC UTILITY OF GONADOTROPHIN-RELEASING HORMONE AGONIST IN POSTMENOPAUSAL HYPERANDROGENISM OF OVARIAN ORIGIN
- Hiperandrogenismo causado por tumor de células de Leydig de ovario